Crescent Biopharma, Inc. · NASDAQ:CBIO
Vestal Point Capital, LP reported a 5.40% stake in Crescent Biopharma, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 17, 2026
Vestal Point Capital, LP reported a 5.40% stake in Crescent Biopharma, Inc., 1,500,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 1,500,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vestal Point Capital, LP | 5.40% | 1,500,000 |
| Ryan Wilder | 5.40% | 1,500,000 |